Clinical Trials Directory

Trials / Completed

CompletedNCT04304287

The Benefit of Autologous Blood Transfusion in Total Hip Arthroplasty

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
75 (actual)
Sponsor
Clinical Hospital Centre Zagreb · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The investigators studied the benefit of preoperative autologous blood donation in participants who undergo total hip arthroplasty. Study is made as a prospective and randomized.

Detailed description

Total hip arthroplasty is procedure followed with large perioperative and postoperative blood loss. In order to avoid the application of large amounts of allogeneic blood, preoperative autologous blood donation as a tipe of autologous transfusion have been developed. In this study, the investigators studied the benefit of preoperative autologous blood donation in participants who undergo total hip arthroplasty. Study is made as a prospective and randomized. Participants were divided into three groups: the first group donated one dose of autologous blood 14 days preoperatively, the second group donated one dose of autologous blood 72 hours preoperatively and a third group was not donated autologous blood. The blood parameters, hemodynamic stability, bleeding, the need for application of autologous or homologous blood and length of hospital stay were compared.

Conditions

Interventions

TypeNameDescription
PROCEDUREPreoperative autologous blood donation, 14 days before surgery
PROCEDUREPreoperative autologous blood donation, 72 hours before surgery
PROCEDUREWithout preoperative blood donation

Timeline

Start date
2011-01-16
Primary completion
2013-06-15
Completion
2015-06-15
First posted
2020-03-11
Last updated
2020-03-23

Source: ClinicalTrials.gov record NCT04304287. Inclusion in this directory is not an endorsement.